Skip to main content
Clinical Trials/CTRI/2021/01/030672
CTRI/2021/01/030672
Completed
Phase 3

Comparison of Nalbuphine versus Buprenorphine as an intrathecal adjuvant to hyperbaric Bupivacaine for post operative analgesia in lower limb surgeries.

university college of medical sciences and GTB hospital0 sites46 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
university college of medical sciences and GTB hospital
Enrollment
46
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 31, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
university college of medical sciences and GTB hospital

Eligibility Criteria

Inclusion Criteria

  • Patients belonging to ASA grade 1 and 2 who are undergoing orthopedic lower limb surgery with height \>150cm and \<180cm.

Exclusion Criteria

  • Patients with contraindication to spinal anaesthesia of body weight \>120kg with known allergy to study drug.
  • Patient with history of chronic pain or long term opioid use.
  • Patient refusal.
  • Multiple fractures preventing proper assessment of anaesthesia.

Outcomes

Primary Outcomes

Not specified

Similar Trials